• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在大鼠长期吸入乙醇蒸气后,阿坎酸和地西泮对酒精诱导的行为和皮质改变有不同的调节作用。

Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour.

作者信息

Gewiss M, Heidbreder C, Opsomer L, Durbin P, De Witte P

机构信息

Laboratoire de Psychobiologie, Université de Louvain, Belgium.

出版信息

Alcohol Alcohol. 1991;26(2):129-37. doi: 10.1093/oxfordjournals.alcalc.a045093.

DOI:10.1093/oxfordjournals.alcalc.a045093
PMID:1652250
Abstract

The effects of Acamprosate (the calcium salt of an acetylated form of homotaurine) and the benzodiazepine-receptor agonist Diazepam, were investigated on the alcohol-induced behavioural preference towards alcohol following chronic alcoholization by inhalation. We also examined the effects of Acamprosate and Diazepam on the blood alcohol level (BAL) and on the cortical microvascular network. Acamprosate (50, 100, 200 and 400 mg/kg daily per os during the alcoholization period) did not significantly reduce either BAL or alcohol-induced cortical hypervascularization. Increasing dosages of Acamprosate (i.e. 50, 100, and 200 mg/kg/day), however, progressively reduced preference for alcohol as expressed in a free choice beverage procedure, whereas 400 mg/kg/day of Acamprosate immediately stopped this behaviour. Acamprosate (50 mg/kg/day) also reduced the spontaneous activity of rats during the withdrawal syndrome. By contrast, Diazepam (5 mg/kg) induced inversion in the animals' choice (i.e. increased water consumption versus decreased alcohol intake) during the same experimental procedure, and potentiated the alcohol-induced hypermotility of the animals during the withdrawal syndrome without altering cortical hypervascularization. Taken together, our data provide evidence that both substances exert dose-dependent effects on preference towards alcohol, but display opposite profiles on spontaneous motor activity during the withdrawal phase without any modification of brain microvascularization or blood alcohol levels.

摘要

通过吸入法对大鼠进行慢性酒精化处理后,研究了阿坎酸(同型牛磺酸乙酰化形式的钙盐)和苯二氮䓬受体激动剂地西泮对酒精诱导的行为性酒精偏好的影响。我们还研究了阿坎酸和地西泮对血液酒精水平(BAL)和皮质微血管网络的影响。在酒精化期间,阿坎酸(每天经口给予50、100、200和400 mg/kg)并未显著降低BAL或酒精诱导的皮质血管过度增生。然而,随着阿坎酸剂量增加(即50、100和200 mg/kg/天),在自由选择饮料实验中所表现出的对酒精的偏好逐渐降低,而每天400 mg/kg的阿坎酸可立即阻止这种行为。阿坎酸(50 mg/kg/天)还可降低大鼠在戒断综合征期间的自发活动。相比之下,在相同实验过程中,地西泮(5 mg/kg)可导致动物选择反转(即水摄入量增加而酒精摄入量减少),并在戒断综合征期间增强酒精诱导的动物运动亢进,且不改变皮质血管过度增生。综上所述,我们的数据表明,这两种物质对酒精偏好均有剂量依赖性影响,但在戒断期对自发运动活动呈现相反的作用模式,且对脑微血管化或血液酒精水平无任何改变。

相似文献

1
Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour.在大鼠长期吸入乙醇蒸气后,阿坎酸和地西泮对酒精诱导的行为和皮质改变有不同的调节作用。
Alcohol Alcohol. 1991;26(2):129-37. doi: 10.1093/oxfordjournals.alcalc.a045093.
2
Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex.阿坎酸的作用机制。第二部分。乙醇依赖性改变阿坎酸对大鼠大脑皮质膜中NMDA受体结合的影响。
Alcohol Clin Exp Res. 1998 Jun;22(4):810-4.
3
Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat.阿坎酸与酒精:II. 对大鼠酒精戒断的影响
Eur J Pharmacol. 1996 Jun 3;305(1-3):45-50. doi: 10.1016/0014-2999(96)00175-6.
4
Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release.急性阿坎酸和高牛磺酸对乙醇摄入量及乙醇刺激的中脑边缘多巴胺释放的影响。
Eur J Pharmacol. 2002 Feb 15;437(1-2):55-61. doi: 10.1016/s0014-2999(02)01272-4.
5
The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.甘氨酸摄取抑制剂 Org24598 和安非他酮可减少大鼠的乙醇摄入量;对安非他酮产生耐受性,但对 Org24598 则没有。
Addict Biol. 2012 Sep;17(5):897-907. doi: 10.1111/j.1369-1600.2011.00367.x. Epub 2011 Sep 28.
6
Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.慢性阿坎酸消除了酒精剥夺效应,同时对大鼠乙醇基线反应的影响有限。
Neuropsychopharmacology. 1998 Feb;18(2):125-33. doi: 10.1016/S0893-133X(97)00130-9.
7
Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.阿坎酸。对其在戒酒脱瘾后酒精依赖管理中的药理学及临床潜力的综述。
Drugs. 1997 Jun;53(6):1038-53. doi: 10.2165/00003495-199753060-00008.
8
Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat.阿坎酸与酒精:I. 对大鼠酒精戒断后酒精摄入量的影响。
Eur J Pharmacol. 1996 Jun 3;305(1-3):39-44. doi: 10.1016/0014-2999(96)00174-4.
9
Acamprosate decreases the hypermotility during repeated ethanol withdrawal.阿坎酸可降低反复戒酒期间的运动亢进。
Alcohol. 1999 May;18(1):77-81. doi: 10.1016/s0741-8329(98)00071-8.
10
Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence.阿坎酸在酒精依赖者中作为预处理及戒酒期间对脑功能标志物的药效学作用。
Neuropsychobiology. 2004;50(1):71-7. doi: 10.1159/000077944.

引用本文的文献

1
Acamprosate reduces ethanol intake in the rat by a combined action of different drug components.安非他酮通过不同药物成分的联合作用减少大鼠的乙醇摄入量。
Sci Rep. 2023 Oct 19;13(1):17863. doi: 10.1038/s41598-023-45167-3.
2
Differential Influence of Root Extract and Its Main Isoflavones on Ghrelin Levels in Alcohol-Treated Rats.根提取物及其主要异黄酮对酒精处理大鼠胃饥饿素水平的差异影响
Pharmaceuticals (Basel). 2021 Dec 24;15(1):25. doi: 10.3390/ph15010025.
3
Inhalation of Alcohol Vapor: Measurement and Implications.酒精蒸汽吸入:测量与影响
Alcohol Clin Exp Res. 2017 Feb;41(2):238-250. doi: 10.1111/acer.13291. Epub 2017 Jan 5.
4
Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities.酒精中毒复发预防:最新进展和未来可能。
CNS Drugs. 1997 Apr;7(4):313-27. doi: 10.2165/00023210-199707040-00004.
5
The development of acamprosate as a treatment against alcohol relapse.阿坎酸作为防治酒精复吸治疗药物的研发。
Expert Opin Drug Discov. 2014 Nov;9(11):1355-69. doi: 10.1517/17460441.2014.960840. Epub 2014 Sep 26.
6
P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders.P2X4 受体(P2X4Rs)是预防和/或治疗酒精使用障碍药物研发的新靶点。
Front Neurosci. 2014 Jun 24;8:176. doi: 10.3389/fnins.2014.00176. eCollection 2014.
7
Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders.阿维菌素类药物对乙醇摄入和受体功能有差异影响:开发治疗酒精使用障碍新疗法的意义。
Int J Neuropsychopharmacol. 2014 Jun;17(6):907-16. doi: 10.1017/S1461145713001703. Epub 2014 Jan 22.
8
The clinical pharmacology of acamprosate.阿坎酸的临床药理学。
Br J Clin Pharmacol. 2014 Feb;77(2):315-23. doi: 10.1111/bcp.12070.
9
Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders.近年来,在发现和临床前测试新型化合物以预防和/或治疗酒精使用障碍方面取得了进展。
Alcohol Clin Exp Res. 2013 Jan;37(1):8-15. doi: 10.1111/j.1530-0277.2012.01846.x. Epub 2012 Jun 4.
10
Ivermectin reduces alcohol intake and preference in mice.伊维菌素可减少小鼠的酒精摄入量和偏好。
Neuropharmacology. 2012 Aug;63(2):190-201. doi: 10.1016/j.neuropharm.2012.03.014. Epub 2012 Mar 23.